Triple-negative breast cancer (TNBC) is defined as a breast tumor that is negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2). This evidence concerns the gene ERBB2 and breast neoplasm.